MedPath

Sperogenix Therapeutics Limited

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

PPB:1

Drug Approvals

AGAMREE ORAL SUSPENSION 40MG/ML

Approval Date
Dec 17, 2024
PPB

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.